 | • レポートコード：GIR-107A11731 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、細胞治療処理のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細胞治療処理の種類別市場規模（製品、サービス、ソフトウェア）、用途別市場規模（心血管疾患、骨修復、神経障害、骨格筋修復免疫疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・細胞治療処理の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Anthrogenesis Corp.、BioNTech、Cell Ideas、Epic Sciences、Roche、FuGENE、IBC Pharmaceuticals Inc.、Bluebird Bio Inc.、Immodulon-Therapeutics、Immunomedics Inc.、Juno Therapeutics Inc.、Medlmmune Inc.、NeoStem Oncology、Neurotech USA、Novartis、Persimmune Inc.、Pluristem Therapeutics、BioMed Valley Discoveries Inc.、Regeneron Pharmaceuticals Inc.、UCL Business PLC. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：製品、サービス、ソフトウェア ・用途別分析2016年-2026年：心血管疾患、骨修復、神経障害、骨格筋修復免疫疾患 ・細胞治療処理の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・細胞治療処理のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・細胞治療処理のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・細胞治療処理の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・細胞治療処理の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cell therapy Processing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cell therapy Processing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cell therapy Processing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cell therapy Processing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Products
Services
Software
Market segment by Application, can be divided into
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
Market segment by players, this report covers
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Cell therapy Processing
1.2 Classification of Cell therapy Processing by Type
1.2.1 Overview: Global Cell therapy Processing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cell therapy Processing Revenue Market Share by Type in 2020
1.2.3 Products
1.2.4 Services
1.2.5 Software
1.3 Global Cell therapy Processing Market by Application
1.3.1 Overview: Global Cell therapy Processing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cardiovascular Disease
1.3.3 Bone Repair
1.3.4 Neurological Disorders
1.3.5 Skeletal Muscle RepairImmune Diseases
1.4 Global Cell therapy Processing Market Size & Forecast
1.5 Global Cell therapy Processing Market Size and Forecast by Region
1.5.1 Global Cell therapy Processing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cell therapy Processing Market Size by Region, (2016-2021)
1.5.3 North America Cell therapy Processing Market Size and Prospect (2016-2026)
1.5.4 Europe Cell therapy Processing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cell therapy Processing Market Size and Prospect (2016-2026)
1.5.6 South America Cell therapy Processing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cell therapy Processing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cell therapy Processing Market Drivers
1.6.2 Cell therapy Processing Market Restraints
1.6.3 Cell therapy Processing Trends Analysis
2 Company Profiles
2.1 Anthrogenesis Corp.
2.1.1 Anthrogenesis Corp. Details
2.1.2 Anthrogenesis Corp. Major Business
2.1.3 Anthrogenesis Corp. Cell therapy Processing Product and Solutions
2.1.4 Anthrogenesis Corp. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Anthrogenesis Corp. Recent Developments and Future Plans
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business
2.2.3 BioNTech Cell therapy Processing Product and Solutions
2.2.4 BioNTech Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BioNTech Recent Developments and Future Plans
2.3 Cell Ideas
2.3.1 Cell Ideas Details
2.3.2 Cell Ideas Major Business
2.3.3 Cell Ideas Cell therapy Processing Product and Solutions
2.3.4 Cell Ideas Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Cell Ideas Recent Developments and Future Plans
2.4 Epic Sciences
2.4.1 Epic Sciences Details
2.4.2 Epic Sciences Major Business
2.4.3 Epic Sciences Cell therapy Processing Product and Solutions
2.4.4 Epic Sciences Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Epic Sciences Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Cell therapy Processing Product and Solutions
2.5.4 Roche Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 FuGENE
2.6.1 FuGENE Details
2.6.2 FuGENE Major Business
2.6.3 FuGENE Cell therapy Processing Product and Solutions
2.6.4 FuGENE Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 FuGENE Recent Developments and Future Plans
2.7 IBC Pharmaceuticals Inc.
2.7.1 IBC Pharmaceuticals Inc. Details
2.7.2 IBC Pharmaceuticals Inc. Major Business
2.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Product and Solutions
2.7.4 IBC Pharmaceuticals Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 IBC Pharmaceuticals Inc. Recent Developments and Future Plans
2.8 Bluebird Bio Inc.
2.8.1 Bluebird Bio Inc. Details
2.8.2 Bluebird Bio Inc. Major Business
2.8.3 Bluebird Bio Inc. Cell therapy Processing Product and Solutions
2.8.4 Bluebird Bio Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bluebird Bio Inc. Recent Developments and Future Plans
2.9 Immodulon-Therapeutics
2.9.1 Immodulon-Therapeutics Details
2.9.2 Immodulon-Therapeutics Major Business
2.9.3 Immodulon-Therapeutics Cell therapy Processing Product and Solutions
2.9.4 Immodulon-Therapeutics Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Immodulon-Therapeutics Recent Developments and Future Plans
2.10 Immunomedics Inc.
2.10.1 Immunomedics Inc. Details
2.10.2 Immunomedics Inc. Major Business
2.10.3 Immunomedics Inc. Cell therapy Processing Product and Solutions
2.10.4 Immunomedics Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Immunomedics Inc. Recent Developments and Future Plans
2.11 Juno Therapeutics Inc.
2.11.1 Juno Therapeutics Inc. Details
2.11.2 Juno Therapeutics Inc. Major Business
2.11.3 Juno Therapeutics Inc. Cell therapy Processing Product and Solutions
2.11.4 Juno Therapeutics Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Juno Therapeutics Inc. Recent Developments and Future Plans
2.12 Medlmmune Inc.
2.12.1 Medlmmune Inc. Details
2.12.2 Medlmmune Inc. Major Business
2.12.3 Medlmmune Inc. Cell therapy Processing Product and Solutions
2.12.4 Medlmmune Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Medlmmune Inc. Recent Developments and Future Plans
2.13 NeoStem Oncology
2.13.1 NeoStem Oncology Details
2.13.2 NeoStem Oncology Major Business
2.13.3 NeoStem Oncology Cell therapy Processing Product and Solutions
2.13.4 NeoStem Oncology Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 NeoStem Oncology Recent Developments and Future Plans
2.14 Neurotech USA
2.14.1 Neurotech USA Details
2.14.2 Neurotech USA Major Business
2.14.3 Neurotech USA Cell therapy Processing Product and Solutions
2.14.4 Neurotech USA Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Neurotech USA Recent Developments and Future Plans
2.15 Novartis
2.15.1 Novartis Details
2.15.2 Novartis Major Business
2.15.3 Novartis Cell therapy Processing Product and Solutions
2.15.4 Novartis Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Novartis Recent Developments and Future Plans
2.16 Persimmune Inc.
2.16.1 Persimmune Inc. Details
2.16.2 Persimmune Inc. Major Business
2.16.3 Persimmune Inc. Cell therapy Processing Product and Solutions
2.16.4 Persimmune Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Persimmune Inc. Recent Developments and Future Plans
2.17 Pluristem Therapeutics
2.17.1 Pluristem Therapeutics Details
2.17.2 Pluristem Therapeutics Major Business
2.17.3 Pluristem Therapeutics Cell therapy Processing Product and Solutions
2.17.4 Pluristem Therapeutics Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Pluristem Therapeutics Recent Developments and Future Plans
2.18 BioMed Valley Discoveries Inc.
2.18.1 BioMed Valley Discoveries Inc. Details
2.18.2 BioMed Valley Discoveries Inc. Major Business
2.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Product and Solutions
2.18.4 BioMed Valley Discoveries Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 BioMed Valley Discoveries Inc. Recent Developments and Future Plans
2.19 Regeneron Pharmaceuticals Inc.
2.19.1 Regeneron Pharmaceuticals Inc. Details
2.19.2 Regeneron Pharmaceuticals Inc. Major Business
2.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Product and Solutions
2.19.4 Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Regeneron Pharmaceuticals Inc. Recent Developments and Future Plans
2.20 UCL Business PLC.
2.20.1 UCL Business PLC. Details
2.20.2 UCL Business PLC. Major Business
2.20.3 UCL Business PLC. Cell therapy Processing Product and Solutions
2.20.4 UCL Business PLC. Cell therapy Processing Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 UCL Business PLC. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cell therapy Processing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cell therapy Processing Players Market Share
3.2.2 Top 10 Cell therapy Processing Players Market Share
3.2.3 Market Competition Trend
3.3 Cell therapy Processing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cell therapy Processing Revenue and Market Share by Type (2016-2021)
4.2 Global Cell therapy Processing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cell therapy Processing Revenue Market Share by Application (2016-2021)
5.2 Cell therapy Processing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cell therapy Processing Revenue by Type (2016-2026)
6.2 North America Cell therapy Processing Revenue by Application (2016-2026)
6.3 North America Cell therapy Processing Market Size by Country
6.3.1 North America Cell therapy Processing Revenue by Country (2016-2026)
6.3.2 United States Cell therapy Processing Market Size and Forecast (2016-2026)
6.3.3 Canada Cell therapy Processing Market Size and Forecast (2016-2026)
6.3.4 Mexico Cell therapy Processing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cell therapy Processing Revenue by Type (2016-2026)
7.2 Europe Cell therapy Processing Revenue by Application (2016-2026)
7.3 Europe Cell therapy Processing Market Size by Country
7.3.1 Europe Cell therapy Processing Revenue by Country (2016-2026)
7.3.2 Germany Cell therapy Processing Market Size and Forecast (2016-2026)
7.3.3 France Cell therapy Processing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cell therapy Processing Market Size and Forecast (2016-2026)
7.3.5 Russia Cell therapy Processing Market Size and Forecast (2016-2026)
7.3.6 Italy Cell therapy Processing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cell therapy Processing Revenue by Type (2016-2026)
8.2 Asia-Pacific Cell therapy Processing Revenue by Application (2016-2026)
8.3 Asia-Pacific Cell therapy Processing Market Size by Region
8.3.1 Asia-Pacific Cell therapy Processing Revenue by Region (2016-2026)
8.3.2 China Cell therapy Processing Market Size and Forecast (2016-2026)
8.3.3 Japan Cell therapy Processing Market Size and Forecast (2016-2026)
8.3.4 South Korea Cell therapy Processing Market Size and Forecast (2016-2026)
8.3.5 India Cell therapy Processing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cell therapy Processing Market Size and Forecast (2016-2026)
8.3.7 Australia Cell therapy Processing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cell therapy Processing Revenue by Type (2016-2026)
9.2 South America Cell therapy Processing Revenue by Application (2016-2026)
9.3 South America Cell therapy Processing Market Size by Country
9.3.1 South America Cell therapy Processing Revenue by Country (2016-2026)
9.3.2 Brazil Cell therapy Processing Market Size and Forecast (2016-2026)
9.3.3 Argentina Cell therapy Processing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cell therapy Processing Revenue by Type (2016-2026)
10.2 Middle East & Africa Cell therapy Processing Revenue by Application (2016-2026)
10.3 Middle East & Africa Cell therapy Processing Market Size by Country
10.3.1 Middle East & Africa Cell therapy Processing Revenue by Country (2016-2026)
10.3.2 Turkey Cell therapy Processing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cell therapy Processing Market Size and Forecast (2016-2026)
10.3.4 UAE Cell therapy Processing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Cell therapy Processing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cell therapy Processing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cell therapy Processing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cell therapy Processing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cell therapy Processing Revenue Market Share by Region (2021-2026)
Table 6. Anthrogenesis Corp. Corporate Information, Head Office, and Major Competitors
Table 7. Anthrogenesis Corp. Major Business
Table 8. Anthrogenesis Corp. Cell therapy Processing Product and Solutions
Table 9. Anthrogenesis Corp. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BioNTech Corporate Information, Head Office, and Major Competitors
Table 11. BioNTech Major Business
Table 12. BioNTech Cell therapy Processing Product and Solutions
Table 13. BioNTech Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Cell Ideas Corporate Information, Head Office, and Major Competitors
Table 15. Cell Ideas Major Business
Table 16. Cell Ideas Cell therapy Processing Product and Solutions
Table 17. Cell Ideas Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Epic Sciences Corporate Information, Head Office, and Major Competitors
Table 19. Epic Sciences Major Business
Table 20. Epic Sciences Cell therapy Processing Product and Solutions
Table 21. Epic Sciences Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche Cell therapy Processing Product and Solutions
Table 25. Roche Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. FuGENE Corporate Information, Head Office, and Major Competitors
Table 27. FuGENE Major Business
Table 28. FuGENE Cell therapy Processing Product and Solutions
Table 29. FuGENE Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. IBC Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 31. IBC Pharmaceuticals Inc. Major Business
Table 32. IBC Pharmaceuticals Inc. Cell therapy Processing Product and Solutions
Table 33. IBC Pharmaceuticals Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bluebird Bio Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Bluebird Bio Inc. Major Business
Table 36. Bluebird Bio Inc. Cell therapy Processing Product and Solutions
Table 37. Bluebird Bio Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Immodulon-Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Immodulon-Therapeutics Major Business
Table 40. Immodulon-Therapeutics Cell therapy Processing Product and Solutions
Table 41. Immodulon-Therapeutics Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Immunomedics Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Immunomedics Inc. Major Business
Table 44. Immunomedics Inc. Cell therapy Processing Product and Solutions
Table 45. Immunomedics Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Juno Therapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Juno Therapeutics Inc. Major Business
Table 48. Juno Therapeutics Inc. Cell therapy Processing Product and Solutions
Table 49. Juno Therapeutics Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Medlmmune Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Medlmmune Inc. Major Business
Table 52. Medlmmune Inc. Cell therapy Processing Product and Solutions
Table 53. Medlmmune Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. NeoStem Oncology Corporate Information, Head Office, and Major Competitors
Table 55. NeoStem Oncology Major Business
Table 56. NeoStem Oncology Cell therapy Processing Product and Solutions
Table 57. NeoStem Oncology Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Neurotech USA Corporate Information, Head Office, and Major Competitors
Table 59. Neurotech USA Major Business
Table 60. Neurotech USA Cell therapy Processing Product and Solutions
Table 61. Neurotech USA Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Novartis Corporate Information, Head Office, and Major Competitors
Table 63. Novartis Major Business
Table 64. Novartis Cell therapy Processing Product and Solutions
Table 65. Novartis Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Persimmune Inc. Corporate Information, Head Office, and Major Competitors
Table 67. Persimmune Inc. Major Business
Table 68. Persimmune Inc. Cell therapy Processing Product and Solutions
Table 69. Persimmune Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Pluristem Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. Pluristem Therapeutics Major Business
Table 72. Pluristem Therapeutics Cell therapy Processing Product and Solutions
Table 73. Pluristem Therapeutics Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. BioMed Valley Discoveries Inc. Corporate Information, Head Office, and Major Competitors
Table 75. BioMed Valley Discoveries Inc. Major Business
Table 76. BioMed Valley Discoveries Inc. Cell therapy Processing Product and Solutions
Table 77. BioMed Valley Discoveries Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Regeneron Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors
Table 79. Regeneron Pharmaceuticals Inc. Major Business
Table 80. Regeneron Pharmaceuticals Inc. Cell therapy Processing Product and Solutions
Table 81. Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. UCL Business PLC. Corporate Information, Head Office, and Major Competitors
Table 83. UCL Business PLC. Major Business
Table 84. UCL Business PLC. Cell therapy Processing Product and Solutions
Table 85. UCL Business PLC. Cell therapy Processing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Cell therapy Processing Revenue (USD Million) by Players (2019-2021)
Table 87. Global Cell therapy Processing Revenue Share by Players (2019-2021)
Table 88. Breakdown of Cell therapy Processing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Cell therapy Processing Players Head Office, Products and Services Provided
Table 90. Cell therapy Processing Mergers & Acquisitions in the Past Five Years
Table 91. Cell therapy Processing New Entrants and Expansion Plans
Table 92. Global Cell therapy Processing Revenue (USD Million) by Type (2016-2021)
Table 93. Global Cell therapy Processing Revenue Share by Type (2016-2021)
Table 94. Global Cell therapy Processing Revenue Forecast by Type (2021-2026)
Table 95. Global Cell therapy Processing Revenue by Application (2016-2021)
Table 96. Global Cell therapy Processing Revenue Forecast by Application (2021-2026)
Table 97. North America Cell therapy Processing Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Cell therapy Processing Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Cell therapy Processing Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Cell therapy Processing Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Cell therapy Processing Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Cell therapy Processing Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Cell therapy Processing Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Cell therapy Processing Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Cell therapy Processing Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Cell therapy Processing Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Cell therapy Processing Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Cell therapy Processing Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Cell therapy Processing Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Cell therapy Processing Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Cell therapy Processing Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Cell therapy Processing Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Cell therapy Processing Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Cell therapy Processing Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Cell therapy Processing Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Cell therapy Processing Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Cell therapy Processing Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Cell therapy Processing Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Cell therapy Processing Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Cell therapy Processing Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Cell therapy Processing Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Cell therapy Processing Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Cell therapy Processing Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Cell therapy Processing Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Cell therapy Processing Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Cell therapy Processing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cell therapy Processing Picture
Figure 2. Global Cell therapy Processing Revenue Market Share by Type in 2020
Figure 3. Products
Figure 4. Services
Figure 5. Software
Figure 6. Cell therapy Processing Revenue Market Share by Application in 2020
Figure 7. Cardiovascular Disease Picture
Figure 8. Bone Repair Picture
Figure 9. Neurological Disorders Picture
Figure 10. Skeletal Muscle RepairImmune Diseases Picture
Figure 11. Global Cell therapy Processing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Cell therapy Processing Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Cell therapy Processing Revenue Market Share by Region (2016-2026)
Figure 14. Global Cell therapy Processing Revenue Market Share by Region in 2020
Figure 15. North America Cell therapy Processing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Cell therapy Processing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Cell therapy Processing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Cell therapy Processing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Cell therapy Processing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Cell therapy Processing Market Drivers
Figure 21. Cell therapy Processing Market Restraints
Figure 22. Cell therapy Processing Market Trends
Figure 23. Anthrogenesis Corp. Recent Developments and Future Plans
Figure 24. BioNTech Recent Developments and Future Plans
Figure 25. Cell Ideas Recent Developments and Future Plans
Figure 26. Epic Sciences Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. FuGENE Recent Developments and Future Plans
Figure 29. IBC Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 30. Bluebird Bio Inc. Recent Developments and Future Plans
Figure 31. Immodulon-Therapeutics Recent Developments and Future Plans
Figure 32. Immunomedics Inc. Recent Developments and Future Plans
Figure 33. Juno Therapeutics Inc. Recent Developments and Future Plans
Figure 34. Medlmmune Inc. Recent Developments and Future Plans
Figure 35. NeoStem Oncology Recent Developments and Future Plans
Figure 36. Neurotech USA Recent Developments and Future Plans
Figure 37. Novartis Recent Developments and Future Plans
Figure 38. Persimmune Inc. Recent Developments and Future Plans
Figure 39. Pluristem Therapeutics Recent Developments and Future Plans
Figure 40. BioMed Valley Discoveries Inc. Recent Developments and Future Plans
Figure 41. Regeneron Pharmaceuticals Inc. Recent Developments and Future Plans
Figure 42. UCL Business PLC. Recent Developments and Future Plans
Figure 43. Global Cell therapy Processing Revenue Share by Players in 2020
Figure 44. Cell therapy Processing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Cell therapy Processing Revenue Market Share in 2020
Figure 46. Global Top 10 Players Cell therapy Processing Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Cell therapy Processing Revenue Share by Type in 2020
Figure 49. Global Cell therapy Processing Market Share Forecast by Type (2021-2026)
Figure 50. Global Cell therapy Processing Revenue Share by Application in 2020
Figure 51. Global Cell therapy Processing Market Share Forecast by Application (2021-2026)
Figure 52. North America Cell therapy Processing Sales Market Share by Type (2016-2026)
Figure 53. North America Cell therapy Processing Sales Market Share by Application (2016-2026)
Figure 54. North America Cell therapy Processing Revenue Market Share by Country (2016-2026)
Figure 55. United States Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Cell therapy Processing Sales Market Share by Type (2016-2026)
Figure 59. Europe Cell therapy Processing Sales Market Share by Application (2016-2026)
Figure 60. Europe Cell therapy Processing Revenue Market Share by Country (2016-2026)
Figure 61. Germany Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Cell therapy Processing Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Cell therapy Processing Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Cell therapy Processing Revenue Market Share by Region (2016-2026)
Figure 69. China Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Cell therapy Processing Sales Market Share by Type (2016-2026)
Figure 76. South America Cell therapy Processing Sales Market Share by Application (2016-2026)
Figure 77. South America Cell therapy Processing Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Cell therapy Processing Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Cell therapy Processing Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Cell therapy Processing Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Cell therapy Processing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
世界の細胞療法プロセッシング市場予測（～2024年）：企業別、地域別、種類・用途別 Cell therapy is the transplantation of human cells to replace or repair damaged tissue or cells. With new technologies and innovative products, many different types of cells can be used as part of a therapy or a treatment for a variety of diseases and conditions. Scope of the Report: The global Cell…- 世界の筋骨格系障害幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Musculoskeletal Disorder Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界のCAR T細胞療法市場 2021：企業別、地域別、種類・用途別 The CAR T-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のNK細胞療法市場予測（～2024年）：企業別、地域別、種類・用途別 Description Scope of the Report: The global NK Cell Therapy market is valued at 222.5 million USD in 2018 and is expected to reach 395.4 million USD by the end of 2024, growing at a CAGR of 15.5% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…